Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
GKOS | GLAUKOS Corp | Director | $6.55M | -$2.5M | -27.6% | Feb 26, 2025 |
RVNC | Revance Therapeutics, Inc. | President & CEO, Director | $0 | Feb 4, 2025 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|